Natalie Fryling, OTR/L in Magnolia, DE - Occupational Therapist

Natalie Fryling, OTR/L is a Occupational Therapist - Pediatrics based in Magnolia, Delaware. Natalie Fryling is licensed to practice in Delaware (license number U1-0012414) and her current practice location is 11 E Walnut St, Magnolia, Delaware. She can be reached at her office (for appointments etc.) via phone at (302) 335-5093.

NPI number for Natalie Fryling is 1104546886 and her current mailing address is 4218 Stein Hwy, Seaford, Delaware. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1104546886.

Contact Information

	Natalie Fryling, OTR/L
	11 E Walnut St, Magnolia, DE 19962-9304
	(302) 335-5093
	Not Available

Healthcare Provider's Profile

Full Name	Natalie Fryling
Gender	Female
Speciality	Occupational Therapist - Pediatrics
Location	11 E Walnut St, Magnolia, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1104546886
Provider Enumeration Date: 09/01/2022
Last Update Date: 09/01/2022

Medical Identifiers

Medical identifiers for Natalie Fryling such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104546886	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XP0200X	Occupational Therapist - Pediatrics	U1-0012414 (Delaware)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Natalie Fryling is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Natalie Fryling, OTR/L 4218 Stein Hwy, Seaford, DE 19973-6788 Ph: () -	Natalie Fryling, OTR/L 11 E Walnut St, Magnolia, DE 19962-9304 Ph: (302) 335-5093

News Archive

Study sheds light on Avoidant/Restrictive Food Intake Disorder

When most people think of eating disorders, they think of anorexia nervosa and bulimia nervosa. But there's another condition that has nothing to do with concerns over weight, shape or body image, and it has been recognized in the latest edition of the Diagnostic and Statistical Manual of Mental Disorders, which doctors use to diagnose conditions.

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).

High flavanol diet associated with lower blood pressure

People who consume a diet including flavanol-rich foods and drinks, including tea, apples and berries, could lead to lower blood pressure, according to the first study using objective measures of thousands of UK residents' diet.

HCV-TARGET study: All-oral, direct-acting antiviral therapy for HCV effective in decompensated cirrhosis patients

Interim data presented today at The International Liver Congress 2015 from the HCV-TARGET study show that all-oral, direct-acting antiviral therapy for hepatitis C (HCV) is well tolerated and highly effective in patients with decompensated cirrhosis.

Natalie Fryling, OTR/L - Occupational Therapist in Magnolia, DE